Measure 109 [would allow] therapy using the active ingredient in hallucinogenic mushrooms
The measure does set up a two-year development period that will cost a small sum [the financial impact during the two-year development period, which runs through December of 2022, is estimated to be $7.0 million General Fund to begin activities required under the Act according to the Department of Administrative Services] before the system of…
Recent Comments